GLP1R and type 2 diabetes mellitus: While the biological effectiveness of GIP in inducing insulin secretion by pancreatic β-cells is significantly reduced in T2DM patients, the insulinotropic and glucagonostatic effects of GLP-1 remain largely preserved [127].